Viemed builds acquisition infrastructure
By HME News Staff
Updated 10:17 AM CDT, Mon August 1, 2022
LAFAYETTE, La. – Viemed Healthcare has added Michael Freeman as chief business development officer and Jeremy Trahan as chief legal officer and executive vice president of acquisitions and strategic transactions. Prior to joining Viemed, Freeman and Trahan were executives at LHC Group, where they directed and were integrally involved in more than 100 transactions valued at about $1.9 billion collectively. “We are thrilled to expand our team of extremely talented executives by welcoming Michael and Jeremy,” said Casey Hoyt, Viemed CEO. “Together, they have a proven track record of success and their leadership and experience will support a strong acquisition infrastructure within our organization. I am confident that they will play a critical role in the next major chapter of our organizational growth.” Freeman and Trahan will oversee the acquisition and joint-venture strategies for Viemed. Their responsibilities include sourcing, evaluating and executing corporate transactions, including integration of acquired entities. Previously, Freeman was senior vice president of corporate development for LHC, and Trahan was vice president of legal affairs, transaction counsel for the company.
Comments